JW
Jonathan Wolleben JMP Securities Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Madrigal Pharmaceuticals
MDGL
$9.61B
| $431.21 | $485 |
12%
upside
| Market Outperform | 15 days ago |
|
2
Larimar Therapeutics
LRMR
$331M
| $3.87 | $18 |
365%
upside
| Market Outperform | 16 days ago |
|
3
Pharvaris
PHVS
$1.41B
| $21.98 | $52 |
137%
upside
| Market Outperform | 22 days ago |
|
4
Astria Therapeutics
ATXS
$395M
| $7 | $26 |
271%
upside
| Market Outperform | 22 days ago |
|
5
Crinetics Pharmaceuticals
CRNX
$3.23B
| $34.25 | $86 |
151%
upside
| Market Outperform | 24 days ago |
|
6
Protagonist Therapeutics
PTGX
$3.71B
| $59.60 | $69 |
16%
upside
| Market Outperform | 28 days ago |
|
7
Mirum Pharmaceuticals
MIRM
$3.73B
| $74.18 | $81 |
9%
upside
| Market Outperform | 28 days ago |
|
8
Structure Therapeutics
GPCR
$1.14B
| $19.76 | $87 |
340%
upside
| Market Outperform | 28 days ago |
|
9
Rhythm Pharmaceuticals
RYTM
$6.95B
| $104.57 | $135 |
29%
upside
| Market Outperform | 29 days ago |
|
10
Altimmune
ALT
$314M
| $3.56 | $15 |
321%
upside
| Market Outperform | 1 month ago |
|
11
KalVista Pharmaceuticals
KALV
$765M
| $15.20 | $27 |
78%
upside
| Market Outperform | 1 month ago |
|
12
ProQR Therapeutics
PRQR
$252M
| $2.39 | $8 |
235%
upside
| Market Outperform | 2 months ago |
|
|
DBVT
13
DBV Technologies
DBVT
$252M
| $9.22 | $21 |
128%
upside
| Market Outperform | 2 months ago |
|
14
Aura Biosciences
AURA
$399M
| $6.42 | $19 |
196%
upside
| Market Outperform | 3 months ago |
|
|
MBX
15
MBX Biosciences, Inc. Common Stock
MBX
$434M
| $12.92 | $38 |
194%
upside
| Market Outperform | 4 months ago |
|
|
16
Altimmune
ALT
$314M
| $3.56 | $25 |
602%
upside
| Market Outperform | 5 months ago |
|
|
17
KalVista Pharmaceuticals
KALV
$765M
| $15.20 | $19 |
25%
upside
| Market Outperform | 5 months ago |
|
|
18
Aura Biosciences
AURA
$399M
| $6.42 | $19 |
196%
upside
| Market Outperform | 5 months ago |
|
|
19
Protagonist Therapeutics
PTGX
$3.71B
| $59.60 | $61 |
2%
upside
| Market Outperform | 5 months ago |
|
20
Ocular Therapeutix
OCUL
$2.21B
| $12.70 | $19 |
50%
upside
| Market Outperform | 6 months ago |
|
|
DBVT
21
DBV Technologies
DBVT
$252M
| $9.22 | $10 |
8%
upside
| Market Outperform | 6 months ago |
|
|
22
Pharvaris
PHVS
$1.41B
| $21.98 | $55 |
150%
upside
| Market Outperform | 6 months ago |
|
23
BioCryst Pharmaceuticals
BCRX
$1.74B
| $8.27 | $18 |
118%
upside
| Market Outperform | 6 months ago |
|
|
24
Astria Therapeutics
ATXS
$395M
| $7 | $26 |
271%
upside
| Market Outperform | 6 months ago |
|
|
25
Structure Therapeutics
GPCR
$1.14B
| $19.76 | $87 |
340%
upside
| Market Outperform | 6 months ago |
|